| Infliximab Blood Test in Crohn's Disease (NCT03964883) | Fondation Hôpital Saint-Joseph | 2018-01-01 |
| Effect of the Exclusive Enteral Nutrition Combined With Azathioprine for Remission of Crohn's Diseases After Surgery (NCT04160325) | Zhu Weiming | 2018-01-01 |
| Addressing Depression and Anxiety Symptoms in Patients With Inflammatory Bowel Disease (NCT03327038) | Mount Sinai Hospital, Canada | 2018-01-01 |
| Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes Zoster (NCT03553472) | University of Wisconsin, Madison | 2018-01-01 |
| Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease. (NCT03241368) | Medtronic - MITG | 2017-12-21 |
| A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease (NCT02974322) | Celgene | 2017-12-01 |
| Stopping Aminosalicylate Therapy in Inactive Crohn's Disease (NCT03261206) | Alimentiv Inc. | 2017-11-20 |
| A Multicentre Study on Rifaximin in Post-operative Endoscopic Crohn's Disease Recurrence Prevention (NCT03537157) | Alfasigma S.p.A. | 2017-11-16 |
| Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease (NCT03266484) | Massachusetts General Hospital | 2017-11-13 |
| Reverse Engineering of Exclusive Enteral Nutrition (NCT03508193) | Dale Lee | 2017-11-04 |
| Prospective Observational Study on Ustekinumab (Stelara) Assessing Efficacy and Healthcare Resource Utilization in Crohn's Disease (NCT03495973) | Janssen-Cilag Ltd. | 2017-10-25 |
| CD-TREAT Diet: a Novel Therapy for Active Luminal Crohn's Disease (NCT03171246) | NHS Greater Glasgow and Clyde | 2017-10-23 |
| Stem Cell Coated Fistula Plug in Patients With Crohn's RVF (NCT03220243) | Mayo Clinic | 2017-10-19 |
| Stricture Definition and Treatment (STRIDENT) Drug Therapy Study (NCT03220841) | St Vincent's Hospital Melbourne | 2017-10-09 |
| Stricture Definition and Treatment (STRIDENT) Observational Study. (NCT03218202) | St Vincent's Hospital Melbourne | 2017-10-09 |
| Stricture Definition and Treatment (STRIDENT) Endoscopic Therapy Study (NCT03222011) | St Vincent's Hospital Melbourne | 2017-10-09 |
| FMT in Pediatric Crohn's Disease (NCT03194529) | Children's Hospital Los Angeles | 2017-10-09 |
| Immunological Profiles in Inflammatory Bowel Disease (NCT03366090) | Rijnstate Hospital | 2017-10-01 |
| Counseling to Optimize Adherence in Expectant Mothers With Inflammatory Bowel Disease (NCT03091309) | Mount Sinai Hospital, Canada | 2017-10-01 |
| The IMAGINE-SPOR CIHR Chronic Disease Network (NCT03131414) | Hamilton Health Sciences Corporation | 2017-10-01 |
| Mesenteric Sparing for the Prevention of Recurrent Crohn's Disease (NCT03172143) | Mayo Clinic | 2017-08-29 |
| Effectiveness of Rifaximin on Preventing Postoperative Recurrence in Crohn's Disease (NCT03185624) | Sixth Affiliated Hospital, Sun Yat-sen University | 2017-07-25 |
| Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis (NCT03169894) | Avalo Therapeutics, Inc. | 2017-07-14 |
| Fistulodesis Pilot Study for Closure of Perianal Fistulae (NCT03322488) | University of Zurich | 2017-06-20 |
| Fecal Microbial Transplantation in Patients With Crohn's Disease (NCT03267238) | Stony Brook University | 2017-06-16 |
| Ultrasound Evaluation of Crohn's Disease (NCT03235180) | Mayo Clinic | 2017-06-16 |
| The Therapy Effect of Azathioprine Initial or 14 Weeks After Combined With Infliximab on CD (NCT03393247) | Sixth Affiliated Hospital, Sun Yat-sen University | 2017-06-01 |
| Histopathologic and Lymphocyte Subpopulations Evaluation of the Upper Gastrointestinal Tract of Crohn's Disease (NCT05874349) | Hospital Mutua de Terrassa | 2017-06-01 |
| Comparison of Partial and Exclusive Enteral Nutrition in the Treatment of Active Childhood-onset Crohn's Disease (NCT03176875) | University Medical Centre Ljubljana | 2017-05-25 |
| Effectiveness of Rifaximin Combined With Thiopurine on Preventing Postoperative Recurrence in Crohn's Disease (NCT03185611) | Sixth Affiliated Hospital, Sun Yat-sen University | 2017-05-18 |
| Lengthening Adalimumab Dosing Interval in Quiescent Crohn's Disease Patients (NCT03172377) | Radboud University Medical Center | 2017-05-03 |
| Self Screening Tool for Crohn's Perianal Fistula (NCT03288961) | Kyungpook National University Hospital | 2017-05-01 |
| Fecal Calprotectin Collection Protocol (NCT03143517) | DiaSorin Inc. | 2017-04-19 |
| Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab (NCT03107793) | Janssen-Cilag Ltd. | 2017-04-19 |
| Triple Combination Therapy in High Risk Crohn's Disease (CD) (NCT02764762) | Takeda | 2017-04-18 |
| Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease (NCT03108326) | Ced Service GmbH | 2017-04-15 |
| Surgically Resected Crohn's Disease Patients: Prognostic Factors for Re-operation and New Score Building (NCT03150238) | Istituto Clinico Humanitas | 2017-04-13 |
| Synergistic Effect of Vedolizumab and Pentoxifylline (NCT02953275) | University of Miami | 2017-04-13 |
| IBD Self-management Website and Home Faecal Calprotectin Monitoring (NCT03671980) | University Hospital Southampton NHS Foundation Trust | 2017-04-04 |
| Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets (NCT03090139) | Takeda | 2017-03-28 |
| Fecal Transplant for Crohn's Disease (NCT03078803) | University of Alberta | 2017-03-28 |
| A Study to Determine the Safety and Immunogenicity of a Candidate MAP Vaccines ChAdOx2 HAV and MVA in Healthy Adult Volunteers (NCT03027193) | University of Oxford | 2017-03-15 |
| Study of Gut Microbiota in Crohn's Disease Patients Suffering From Spondylarthritis (NCT03072836) | Central Hospital, Nancy, France | 2017-03-06 |
| The Norwegian Drug Monitoring Study (NCT03074656) | Diakonhjemmet Hospital | 2017-03-01 |
| OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome (NCT03051204) | University of California, Los Angeles | 2017-02-28 |
| The Biologic Onset of Crohn's Disease: A Screening Study in First Degree Relatives (NCT03291743) | Carilion Clinic | 2017-02-10 |
| Effect of Exclusive Enteral Nutrition on Disease Process, Nutritional Status and Gastrointestinal Microbiota for Chinese Children With Crohn's Disease (NCT03755583) | Children's Hospital of Fudan University | 2017-02-01 |
| Association of Breg and Treg With the Clinical Effects of Infliximab in the Treatment of Patients With Crohn's Disease (NCT04272788) | Second Affiliated Hospital of Wenzhou Medical University | 2017-01-24 |
| A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease (NCT02968108) | Janssen Research & Development, LLC | 2017-01-18 |
| A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn´s Disease (CD) (NCT02986724) | Takeda | 2017-01-04 |
| PIBD-SETQuality: the Inception Cohort and Safety Registry (NCT03571373) | Erasmus Medical Center | 2017-01-03 |
| Inflammatory Bowel Disease in South Eastern Norway (NCT02727959) | Oslo University Hospital | 2017-01-01 |
| Comprehensive DNA Methylation Profiling in Crohn's Disease (NCT03272152) | Jinling Hospital, China | 2017-01-01 |
| Zurich Fistula Cohort Study (NCT03003351) | University of Zurich | 2017-01-01 |
| Yoga for Youth With IBD: a Pilot Feasibility Study (NCT04757935) | Stanford University | 2017-01-01 |
| Diet as Essential Therapy (DIET) for Inflammatory Bowel Disease (NCT03012542) | University of Washington | 2017-01-01 |
| Effects of Supplementation of Vitamin D in Patients With Crohn's Disease (NCT02704624) | Federal University of Juiz de Fora | 2016-12-01 |
| Circadian Misalignment in Inflammatory Bowel Disease (NCT04637399) | Rush University Medical Center | 2016-11-22 |
| A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial (NCT03183661) | Anterogen Co., Ltd. | 2016-11-16 |
| Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study (NCT02760615) | Takeda | 2016-11-01 |
| The PRognostic Effect of Environmental Factors in Crohn's and Colitis (NCT03282903) | University of Edinburgh | 2016-11-01 |
| Thalidomide Results in Diminished Ovarian Reserve in Reproductive Age Female IBD Patients (NCT02998827) | Sixth Affiliated Hospital, Sun Yat-sen University | 2016-11-01 |
| National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life (NCT02925338) | Pfizer | 2016-10-19 |
| Induced Adult Refractory Active Crohn's Disease Clinical Relieving by Using Thalidomide (NCT02956538) | Sixth Affiliated Hospital, Sun Yat-sen University | 2016-10-01 |
| BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity (NCT02871635) | Boehringer Ingelheim | 2016-09-28 |
| Unraveling a Potential Connection Between Bilirubin Metabolism, Gut Microbiota and Inflammatory Bowel Diseases (NCT03841045) | Soroka University Medical Center | 2016-09-14 |
| Effectiveness of Vedolizumab in CD Patients Naïve to Anti-TNF (NCT02820493) | Universita degli Studi di Genova | 2016-09-01 |
| Genomic/Epigenomic Biomarkers of Deregulation of Immune System in Inflammatory Bowel Diseases (NCT02878395) | Central Hospital, Nancy, France | 2016-09-01 |
| Autoimmune Protocol Diet and Inflammatory Bowel Disease (NCT03512327) | Scripps Health | 2016-09-01 |
| Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease (NCT02877134) | Janssen Research & Development, LLC | 2016-08-25 |
| Comparison of Intracorporeal and Extracorporeal Anastomoses for Minimally Invasive Right Colectomy (NCT03019016) | Intuitive Surgical | 2016-08-01 |
| Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease (NCT02743806) | Takeda | 2016-08-01 |
| Prucalopride Prior to Small Bowel Capsule Endoscopy (NCT02806206) | University of British Columbia | 2016-07-01 |
| Value of Pharmacokinetic Assays in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's Disease (NCT02768532) | Centre Hospitalier Universitaire de Saint Etienne | 2016-07-01 |
| Advanced Non-Invasive Diagnostics in Inflammatory Bowel Disease (NCT03134586) | Esbjerg Hospital - University Hospital of Southern Denmark | 2016-06-01 |
| Initial Experience With a Novel Single-Balloon Enteroscopy System in Children With IBD (NCT02629211) | Smart Medical Systems Ltd. | 2016-06-01 |
| Improving the Health Care in Inflammatory Bowel Disease. (NCT02770599) | University Hospital of North Norway | 2016-05-15 |
| Micro-fragmented Adipose Tissue and Complex Crohns' Anal Fistulas (NCT03555773) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2016-05-11 |
| Biodegradable Stenting Anastomoses Versus Double-layer Hand Sutures for Reconstruction in Intestinal Anastomosis (NCT02752360) | Beijing Friendship Hospital | 2016-04-01 |
| Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction Destiny (NCT02634060) | Universitaire Ziekenhuizen KU Leuven | 2016-03-31 |
| The Effect of Riboflavin in Crohn's Disease (NCT02538354) | University Medical Center Groningen | 2016-03-01 |
| Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases (NCT02925351) | Jonsson Comprehensive Cancer Center | 2016-01-25 |
| Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease (NCT02596893) | Celgene | 2015-12-08 |
| Magnetic Resonance Imaging of Motility in Crohn's 2 (NCT03052465) | University of Nottingham | 2015-11-16 |
| Telephone-based Motivational Interviewing for Smoking Cessation in Crohn's Disease Patients (NCT04225403) | Hospital Universitari Vall d'Hebron Research Institute | 2015-11-06 |
| Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis (NCT02330653) | Stacy A. Kahn | 2015-11-01 |
| Effect of UGIR in Adults With Compromised Gut Function and Malabsorption (NCT03011593) | Metagenics, Inc. | 2015-11-01 |
| Surgical Prevention of Anastomotic Recurrence by Excluding Mesentery in Crohn's Disease (NCT02631967) | Federico II University | 2015-11-01 |
| An Innovative Treatment for Fistula-in-ano in Crohn Disease : Local Micro Reinjection of Autologous Fat and SVF (NCT02520843) | Assistance Publique Hopitaux De Marseille | 2015-10-01 |
| Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System (NCT04573959) | Capso Vision, Inc. | 2015-10-01 |
| A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's Disease (NCT02513459) | AbbVie | 2015-09-16 |
| Characterization of CD Responders to Vedolizumab (NCT04909359) | University of Miami | 2015-08-25 |
| Crohn Disease Exclusion Diet After Single Medication De-escalation (NCT02472457) | Children's Hospital of Philadelphia | 2015-08-01 |
| Effect of Biologic Therapy on Surgical Outcomes for Perforated Crohn's Patients (NCT06511921) | Zagazig University | 2015-07-09 |
| A Study to Evaluate Efficacy, of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study (NCT02646683) | Geert D'Haens | 2015-07-01 |
| Description of Perianal Lesions in a Cohort of Crohn's Disease Patients (NCT02899013) | Fondation Hôpital Saint-Joseph | 2015-07-01 |
| Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 (NCT02403323) | Hoffmann-La Roche | 2015-06-08 |
| Thrombin Generation in Crohn's Disease (NCT02445690) | University of Sao Paulo General Hospital | 2015-05-01 |
| Efficacy of Fecal Microbiota Transplantation for Inflammatory Bowel Disease (NCT02575040) | Saglik Bilimleri Universitesi Gulhane Tip Fakultesi | 2015-05-01 |
| Effect of Acupuncture on the Microbiota-gut-brain Axis in Crohn's Disease (NCT06364722) | Shanghai Institute of Acupuncture, Moxibustion and Meridian | 2015-05-01 |